Displaying 1 - 13 of 13
| Active Ingredient | BETAMETHASONE |
| Therapeutic Class | ADRENALS |
| Indications | Suppression of inflammatory and allergic disorders. |
| Caution | Adrenal suppression. Gastro Intestinal distress, euphoria/depression. |
| Dose Range | Adult: 0.5-5mg daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEFLAZACORT |
| Therapeutic Class | ADRENALS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEXAMETHASONE |
| Therapeutic Class | ADRENALS |
| Indications |
Suppression of inflammatory and allergic disorders; shock; diagnosis of cushings disease. |
| Caution | See Betamethasone. |
| Dose Range |
Adult: 0.5-10mg daily in single or divided doses. Pediatric: 10- 100mcg/kg daily in 1-2 divided doses; (up to 300mcg/kg daily may be required in emergency situations). |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEXAMETHASONE SODIUM PHOSPHATE |
| Therapeutic Class | ADRENALS |
| Indications | Suppression of inflammatory and allergic disorders. |
| Caution | Adrenal suppression. Gastro Intestinal distress, euphoria/depression. |
| Dose Range |
Adult: i.m., slow i.v. injection or infusion 0.5-20mg. Pediatric: 200-500mg/kg daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUDROCORTISONE |
| Therapeutic Class | ADRENALS |
| Indications | Mineralocorticoid replacement in adrenocortical insufficiency . |
| Caution | Edema, electrolyte abnormalities, growth suppression in children. |
| Dose Range |
Adult: 50-300mcg daily. Pediatric: Initially 50mcg-100mcg daily; maintenance 50-300mcg daily adjusted according to response. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | HYDROCORTISONE |
| Therapeutic Class | ADRENALS |
| Indications | For anti-inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, allergic disorders. |
| Caution | Hypertension, sodium retention and potassium loss, diabetes, muscle weakness and myopathy , osteoporosis, mental changes, gastrointestinal upset and peptic ulcer; growth retardation in More ... |
| Dose Range | Adult: 20-30 mg daily in divided doses. Pediatric: 1 month to 18 yrs: initially 6-7 mg/m2 every 8 hours adjusted according to resp onse. Maintenance dose: 4-5 mg/m2 every 8 hours. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | HYDROCORTISONE SODIUM SUCCINATE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone.For anti inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, allergic disorders. |
| Caution |
hypertension sodium retention water retention potassium loss calcium loss |
| Dose Range | Adult: i.m., slow i.v. inj. Or infusion: 100-500mg, 3-4 times in 24 hrs. Pediatric: neonates: 10 mg as a slow inj. Then 100 mg/m2/day as a continuous infusion or in divided doses every 6-8 hrs; reduced over 4-5 day s to an oral maintenance dose. 1 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | METHYLPREDNISOLONE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone. |
| Caution | See Hydrocortisone. |
| Dose Range |
Adult: i.m. slow i.v. injection or infusion 10-500mg. Pediatric: 0.5-1.7mg/kg every 6-12 hours. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone.For anti inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, allergic disorders. |
| Caution | See Hydrocortisone.Hypertension, sodium retention and potassium loss, diabetes, muscle weakness and myopathy, osteoporosis, mental changes, gastrointestinal upset and peptic ulcer; growth retardation More ... |
| Dose Range | See Methylprednisolone Acetate.Adult:i.m. slow i.v. injection or infusion 10-500mg. Pediatric: 0.5-1.7mg/kg every 6-12 hours. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PREDNISOLONE |
| Therapeutic Class | ADRENALS |
| Indications |
Drug of choice for most conditions requiring oral corticosteroids, for anti-inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, ulcerative colitis, myasthenia gravis. |
| Caution | Hypertension, sodium retention and potassium loss, diabetes, muscle weakness and myopathy , osteoporosis, mental changes, gastro-intestinal up set and peptic ulcer; growth retardation in ch More ... |
| Dose Range | Adult: 2.5- 60 mg daily in divided doses, as a single daily dose after breakfast, or as a double dose on alternate days. Pediatric: 1 month to 18 y rs:1-2mg/kg/day (M ax. 60mg/day ), then reduce after a few days if appropriate. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TRIAMCINOLONE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone. |
| Caution | Avoid in chronic use. |
| Dose Range | 40mg repeated at intervals. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DANAZOL |
| Therapeutic Class | ANDROGENS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TESTOSTERONE |
| Therapeutic Class | ANDROGENS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |